Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Vaknin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cells|February 9, 2024
The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical DataRaanan Greenman, Tom Snir, Avi Katav, et al.
The American Journal of Gastroenterology|November 19, 2025
Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 StudyChristopher L Bowlus, Douglas Thorburn, Stephen T Barclay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2013
CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain agingKuti Baruch, Noga Ron-Harel, Hilah Gal, et al.
Cancer Immunology Research|January 20, 2019
Mouse PVRIG Has CD8<sup>+</sup> T Cell-Specific Coinhibitory Functions and Dampens Antitumor ImmunityBenjamin Murter, Xiaoyu Pan, Eran Ophir, et al.
Cancer Immunology Research|April 22, 2020
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)Julia Huetter, Uwe Gritzan, Ilona Gutcher, et al.
Cancer Immunology Research|January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8<sup>+</sup> T-cell FunctionSarah Whelan, Eran Ophir, Maya F Kotturi, et al.
JCI Insight|June 22, 2023
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitisRaanan Greenman, Michal Segal-Salto, Neta Barashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell ResponsesIris Hecht, Amir Toporik, Joseph R Podojil, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cells|February 9, 2024
The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical DataRaanan Greenman, Tom Snir, Avi Katav, et al.
The American Journal of Gastroenterology|November 19, 2025
Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 StudyChristopher L Bowlus, Douglas Thorburn, Stephen T Barclay, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2013
CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain agingKuti Baruch, Noga Ron-Harel, Hilah Gal, et al.
Cancer Immunology Research|January 20, 2019
Mouse PVRIG Has CD8<sup>+</sup> T Cell-Specific Coinhibitory Functions and Dampens Antitumor ImmunityBenjamin Murter, Xiaoyu Pan, Eran Ophir, et al.
Cancer Immunology Research|April 22, 2020
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)Julia Huetter, Uwe Gritzan, Ilona Gutcher, et al.
Cancer Immunology Research|January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8<sup>+</sup> T-cell FunctionSarah Whelan, Eran Ophir, Maya F Kotturi, et al.
JCI Insight|June 22, 2023
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitisRaanan Greenman, Michal Segal-Salto, Neta Barashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell ResponsesIris Hecht, Amir Toporik, Joseph R Podojil, et al.
Pageof 2